ABVC
ABVC BioPharma Inc.
$2.87
+$0.03(+1.06%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$66.86M
Volume
67.44K
52W Range
$0.40 - $5.48
Target Price
$20.20
Order:
Income Statement
| Metric | Trend | Chart | 2014 Sep | 2016 Sep | 2017 Sep | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | -- | -- | -- | $-186.1K | $491.6K | $483.0K | $355.8K | $969.8K | $218.3K | $558.1K | ||
| Total Revenue | -- | -- | -- | $7.0K | $491.6K | $483.0K | $355.8K | $969.8K | $152.4K | $509.6K | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | -- | $-32 | -- | $-185.3K | $20.1K | $18.7K | $5.1K | $286.4K | $302.0K | $763 | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | -- | $-32 | -- | $-178.3K | $471.5K | $464.3K | $350.7K | $683.4K | $-149.6K | $508.8K | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | -- | $11.0M | $4.0M | $-2.6M | $4.1M | $9.0M | $12.1M | $15.8M | $6.6M | $5.2M | ||
| Research & Development | -- | $10.0M | $3.2M | $988.7K | $1.0M | $549.7K | $1.0M | $2.7M | $1.1M | $179.3K | ||
| Research Expense | -- | $10.0M | $3.2M | $988.7K | $1.0M | $549.7K | $1.0M | $2.7M | $1.1M | $179.3K | ||
| Selling, General & Administrative | -- | $599.3K | $707.1K | $1.6M | $3.1M | $4.3M | $11.1M | $6.1M | $5.4M | $2.3M | ||
| Selling & Marketing Expenses | -- | $599.3K | $707.1K | $1.6M | $3.1M | -- | $5.3M | $7.0M | -- | -- | ||
| General & Administrative Expenses | -- | $-29.1K | $-61.1K | $-7.5K | $-4.5M | $4.3M | $5.8M | $6.1M | $5.4M | $2.3M | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | -- | -- | $7.0M | -- | -- | ||
| Salaries & Wages | -- | $398.0K | $138.0K | $28.8K | $22.3K | $4.1M | $5.3M | $7.0M | $185.9K | $2.8M | ||
| Depreciation & Amortization | -- | -- | -- | $-43.6K | $-55.1K | $37.1K | $12.0K | $23.8K | $28.5K | -- | ||
| Depreciation & Amortization | -- | -- | -- | $-43.6K | $-55.1K | $37.1K | $12.0K | $286.4K | -- | -- | ||
| Amortization | -- | -- | -- | -- | -- | $37.1K | $1.5M | $286.4K | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | $-1.4M | $-301.4K | $337.3K | $335.2K | $358.6K | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | -- | $-11.0M | $-4.0M | $-3.0M | $-3.7M | $-8.5M | $-11.7M | $-15.1M | $-6.8M | $-4.7M | ||
| EBITDA | -- | $-11.0M | $-4.0M | $-3.9M | $-3.5M | $-10.4M | $-11.0M | $-15.2M | $-6.3M | $-4.3M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | $10.2K | $75.0K | $462.8K | $482.0K | $405.0K | $227.2K | $294.0K | $1.3M | $825.9K | ||
| Intinc | -- | $361 | $149 | $5.2K | $27.7K | $1.3K | $43.2K | $187.8K | $185.5K | $87.4K | ||
| Net Non-Operating Interest Income/Expense | -- | $-9.8K | $-74.8K | $-457.5K | $-454.3K | $-405.0K | $-184.0K | $106.2K | $-1.1M | $-738.5K | ||
| Gain on Sale of Securities | -- | -- | -- | $-395.5K | -- | $-1.2M | $-269.8K | $-7.4K | $-221.9K | $-339.2K | ||
| Other Income/Expense | -- | -- | -- | $400.6K | $-93.0K | $957.4K | $-252.8K | $-294.0K | $218.5K | $204.7K | ||
| Other Special Charges | -- | -- | -- | $-5.2K | $93.0K | $270.7K | $161.8K | $83.0K | $3.4K | $134.4K | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | -- | -- | $-2.6M | $19.5K | $-961.2K | $-741.4K | $-110.1K | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | $2.6M | -- | $961.2K | $741.4K | $110.1K | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | -- | $-11.0M | $-4.0M | $-3.9M | $-3.5M | $-10.4M | $-11.0M | $-15.2M | $-6.7M | $-4.5M | ||
| Pre-Tax Income | -- | $-11.0M | $-4.1M | $-6.4M | $-4.0M | $-10.8M | $-11.2M | $-15.5M | $-8.0M | $-5.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | -- | $836 | $830 | $-365.1K | $-77.0K | $-220.4K | $825.0K | $797.8K | $256.0K | $-110.5K | ||
| NET INCOME | ||||||||||||
| Net Income | $-23.2K | $-11.0M | $-4.1M | $-5.6M | $-3.6M | $-9.8M | $-12.8M | $-16.4M | $-7.8M | $-4.9M | ||
| Net Income (Continuing Operations) | $-23.2K | $-11.0M | $-4.1M | $-5.6M | $-3.6M | $-10.6M | $-12.8M | $-16.3M | $-8.3M | $-5.3M | ||
| Net Income (Discontinued Operations) | $-23.2K | $-11.0M | $-4.1M | $-5.6M | $-3.6M | $-9.8M | $-12.8M | $-16.4M | $-7.8M | $-4.9M | ||
| Net Income (Common Stockholders) | $-23.2K | $-11.0M | $-4.1M | $-5.6M | $-3.6M | $-9.8M | $-12.8M | $-16.4M | $-7.8M | $-4.9M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-8.5M | -- | -- | $-5.5M | ||
| TOTALS | ||||||||||||
| Total Expenses | -- | $11.0M | $4.0M | $-2.8M | $4.2M | $9.0M | $12.1M | $16.1M | $6.9M | $5.2M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | -- | $10.8M | $212.6M | $11.9M | $1.7M | $2.0M | $2.5M | $3.2M | $4.3M | $11.7M | ||
| Average Shares Outstanding (Diluted) | -- | $10.8M | $212.6M | $11.9M | $1.7M | -- | $2.5M | $3.0M | $4.3M | $11.7M | ||
| Shares Outstanding | $23.5M | $11.7M | $213.7M | $11.9M | $1.9M | $2.4M | $3.0M | $3.3M | $23.5M | $23.5M | ||
| Basic EPS | -- | $0.36 | $-0.02 | $-0.36 | -- | $-5 | $-5.1 | $-5.2 | $-2.43 | $-0.42 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-5 | $-5.1 | $-5.2 | $-2.43 | $-0.42 | ||
| Diluted EPS | -- | $-0.36 | $-0.02 | $-0.36 | $-2.1 | $-5 | $-5.1 | $-5 | $-2.43 | $-0.42 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-2.1 | -- | $-5.1 | $-5 | -- | $-0.42 | ||
| OTHER METRICS | ||||||||||||
| Acquired In Process Rn D Income | -- | -- | -- | -- | -- | -- | $360.9K | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | $-193.0K | $-210.1K | -- | $-269.8K | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | $-193.0K | $-210.1K | -- | $-269.8K | -- | -- | -- | ||
| Insurance And Claims | -- | -- | -- | -- | -- | -- | $5.1K | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | $-8.5K | $-281 | -- | -- | -- | -- | -- | -- | ||
| Marketing Expense | -- | -- | -- | -- | -- | -- | $5.1K | -- | -- | -- | ||
| Minority Interests | -- | -- | -- | $489.2K | $291.5K | $802.4K | $-803.0K | $-110.9K | $492.8K | $356.2K | ||
| Other Gand A | -- | $-29.1K | $-61.1K | $-7.5K | $-4.5M | $4.3M | $5.8M | $6.1M | $5.4M | $2.3M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $2.5M | -- | $961.2K | -- | -- | -- | -- | ||
| Other Taxes | -- | -- | -- | -- | -- | -- | $698.2K | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | $18.7K | -- | -- | -- | -- | ||
| Rent And Landing Fees | -- | $-29.1K | $-61.1K | $-7.5K | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | $599.3K | $707.1K | $1.6M | $3.1M | -- | -- | -- | -- | -- | ||
| Write Down | -- | -- | -- | -- | -- | $18.7K | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | $-11.9K | $-19.5K | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ABVC | $2.87 | +1.1% | 67.44K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |